1. Assemble and report on a periodic basis, cancer incidence rates in SEER areas, and cancer mortality rates in the United States; 2. Monitor annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics; 3. Provide continuing information on changes over time in the extent of disease at diagnosis, therapy, and associated changes in cancer patient survival; 4. Implement specific studies designed to identify factors amenable to cancer control interventions including environmental, occupational, socioeconomic, dietary, and health-related exposures; and screening practices, early detection, treatment and other determinants of the extent and quality of patient survival.
| Thompson, Deborah; Easton, Douglas; Breast Cancer Linkage Consortium (2002) Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev 11:329-36 |
| Narod, S A; Sun, P; Ghadirian, P et al. (2001) Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet 357:1467-70 |
| Slattery, M L; Anderson, K; Samowitz, W et al. (1999) Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA). Cancer Causes Control 10:467-73 |
| Yakovlev, A Y; Tsodikov, A D; Boucher, K et al. (1999) The shape of the hazard function in breast carcinoma: curability of the disease revisited. Cancer 85:1789-98 |
